Teva Pharmaceutical Indus TEVA reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Teva Pharmaceutical Indus missed estimated earnings by 4.84%, reporting an EPS of $0.59 versus an estimate of $0.62.
Revenue was down $292.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 28.37% increase in the share price the next day.
Here's a look at Teva Pharmaceutical Indus's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | 0.57 | 0.55 | 0.73 | 0.65 |
EPS Actual | 0.68 | 0.55 | 0.77 | 0.59 |
Revenue Estimate | 3.78B | 3.75B | 4.29B | 4.03B |
Revenue Actual | 3.79B | 3.66B | 4.10B | 3.89B |
To track all earnings releases for Teva Pharmaceutical Indus visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.